Cargando…
Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
BACKGROUND: Colitis is one of the immune-related side effects of immunotherapy. Usually, such type of side effect was reported to develop within a few weeks of treatment initiation, our case started within a few days. CASE SUMMARY: We present a case of a 37-year-old gentleman with bright red loose s...
Autores principales: | Abu Khalaf, Suha, Albarrak, Abdulmajeed, Yousef, Mohamad, Tahan, Veysel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340999/ https://www.ncbi.nlm.nih.gov/pubmed/32699584 http://dx.doi.org/10.4251/wjgo.v12.i6.699 |
Ejemplares similares
-
Infliximab use in ulcerative colitis flare with clostridium difficile infection: A report of two cases and literature review
por: Romana, Bhupinder S., et al.
Publicado: (2018) -
Overlapping Hepatotoxicity and Colitis Associated with Immune Checkpoint Inhibitors
por: Malik, Alexander, et al.
Publicado: (2023) -
Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017) -
Immune checkpoint inhibitors: here to stay
por: Carvalho, Filomena Marino, et al.
Publicado: (2023) -
Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
por: Khan, Jaffar, et al.
Publicado: (2021)